title: Drug companies accused of stalling tailored therapies.
authors.forename: Gunjan
authors.initials: G
authors.lastname: Sinha
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy / Q000235:genetics; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D010597:Pharmacogenetics / Q000191:economics* / Q000592:standards; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007328:Insulin; D013453:Sulfonylurea Compounds